The global GLP-1 drug delivery device market was valued at $3.6 billion in 2025 and is projected to reach $13.1 billion by 2034, expanding at a robust compound annual growth rate (CAGR) of 16.4% during the forecast period 2026-2034, fueled by an unprecedented surge in GLP-1 receptor agonist drug prescriptions, escalating rates of type 2 diabetes and obesity worldwide, and rapid innovation in patient-centric delivery formats including auto-injectors, wearable patch injectors, and connected smart devices.

https://researchintelo.com/rep....ort/glp-1-drug-deliv